Abstract
As nutrition-related chronic diseases have become more and more frequent, the importance of dietary prevention has also increased. Dietary fat plays a major role in human nutrition, and modification of fat and/or fatty acid intake could have a preventive potential. The aim of the guideline of the German Nutrition Society (DGE) was to systematically evaluate the evidence for the prevention of the widespread diseases obesity, type 2 diabetes mellitus, dyslipoproteinaemia, hypertension, metabolic syndrome, coronary heart disease (CHD), stroke, and cancer through the intake of fat or fatty acids. The main results can be summarized as follows: it was concluded with convincing evidence that a reduced intake of total and saturated fat as well as a larger intake of polyunsaturated fatty acids (PUFA) at the expense of saturated fatty acids (SFA) reduces the concentration of total and low-density lipoprotein cholesterol in plasma. Furthermore, there is convincing evidence that a high intake of trans fatty acids increases risk of dyslipoproteinaemia and that a high intake of long-chain polyunsaturated n-3 fatty acids reduces the triglyceride concentration in plasma. A high fat intake increases the risk of obesity with probable evidence when total energy intake is not controlled for (ad libitum diet). When energy intake is controlled for, there is probable evidence for no association between fat intake and risk of obesity. A larger intake of PUFA at the expense of SFA reduces risk of CHD with probable evidence. Furthermore, there is probable evidence that a high intake of long-chain polyunsaturated n-3 fatty acids reduces risk of hypertension and CHD. With probable evidence, a high trans fatty acid intake increases risk of CHD. The practical consequences for current dietary recommendations are described at the end of this article.
References
1.
Deutsche Gesellschaft für Ernährung (ed): Fettzufuhr und Prävention ausgewählter ernährungsmitbedingter Krankheiten - Evidenzbasierte Leitlinie, ed 2. Bonn, 2015. https://www.dge.de/wissenschaft/leitlinien/ (accessed March 25, 2015).
2.
WHO: Diet, Nutrition and the Prevention of Chronic Diseases: Report of the Joint WHO/FAO Expert Consultation. WHO Technical Report Series 916, 2003.
3.
Hauner H, Bechthold A, Boeing H, Brönstrup A, Buyken A, Leschik-Bonnet E, Linseisen J, Schulze M, Strohm D, Wolfram G: Evidence-based guideline of the German Nutrition Society: carbohydrate intake and prevention of nutrition-related diseases. Ann Nutr Metab 2012;60(suppl 1):1-58.
4.
Jakes RW, Day NE, Luben R, Welch A, Bingham S, Mitchell J, Hennings S, Rennie K, Wareham NJ: Adjusting for energy intake - what measure to use in nutritional epidemiological studies? Int J Epidemiol 2004;33:1382-1386.
5.
Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, Day N: Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 2003;362:212-214.
6.
Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, Troiano RP, Bingham S, Schoeller DA, Schatzkin A, Carroll RJ: Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol 2003;158:14-21; discussion 22-26.
7.
Schatzkin A, Kipnis V: Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 2004;96:1564-1565.
8.
Sheppard L, Kristal AR, Kushi LH: Weight loss in women participating in a randomized trial of low-fat diets. Am J Clin Nutr 1991;54:821-828.
9.
Donnelly JE, Sullivan DK, Smith BK, Jacobsen DJ, Washburn RA, Johnson SL, Hill JO, Mayo MS, Spaeth KR, Gibson C: Alteration of dietary fat intake to prevent weight gain: Jayhawk Observed Eating Trial. Obesity (Silver Spring) 2008;16:107-112.
10.
Heitmann BL, Lissner L, Sørensen TI, Bengtsson C: Dietary fat intake and weight gain in women genetically predisposed for obesity. Am J Clin Nutr 1995;61:1213-1217.
11.
Coakley EH, Rimm EB, Colditz G, Kawachi I, Willett W: Predictors of weight change in men: results from the Health Professionals Follow-Up Study. Int J Obes Relat Metab Disord 1998;22:89-96.
12.
Mosca CL, Marshall JA, Grunwald GK, Cornier MA, Baxter J: Insulin resistance as a modifier of the relationship between dietary fat intake and weight gain. Int J Obes Relat Metab Disord 2004;28:803-812.
13.
Colditz GA, Willett WC, Stampfer MJ, London SJ, Segal MR, Speizer FE: Patterns of weight change and their relation to diet in a cohort of healthy women. Am J Clin Nutr 1990;51:1100-1105.
14.
Field AE, Willett WC, Lissner L, Colditz GA: Dietary fat and weight gain among women in the Nurses' Health Study. Obesity (Silver Spring) 2007;15:967-976.
15.
Summerbell CD, Douthwaite W, Whittaker V, Ells LJ, Hillier F, Smith S, Kelly S, Edmunds LD, Macdonald I: The association between diet and physical activity and subsequent excess weight gain and obesity assessed at 5 years of age or older: a systematic review of the epidemiological evidence. Int J Obes (Lond) 2009;33(suppl 3):S1-S92.
16.
Lissner L, Heitmann BL, Bengtsson C: Low-fat diets may prevent weight gain in sedentary women: prospective observations from the population study of women in Gothenburg, Sweden. Obes Res 1997;5:43-48.
17.
Parker DR, Gonzalez S, Derby CA, Gans KM, Lasater TM, Carleton RA: Dietary factors in relation to weight change among men and women from two southeastern New England communities. Int J Obes Relat Metab Disord 1997;21:103-109.
18.
Forouhi NG, Sharp SJ, Du H, van der A DL, Halkjaer J, Schulze MB, Tjønneland A, Overvad K, Jakobsen MU, Boeing H, Buijsse B, Palli D, Masala G, Feskens EJ, Sørensen TI, Wareham NJ: Dietary fat intake and subsequent weight change in adults: results from the European Prospective Investigation into Cancer and Nutrition cohorts. Am J Clin Nutr 2009;90:1632-1641.
19.
Sánchez-Villegas A, Bes-Rastrollo M, Martínez-González MA, Serra-Majem L: Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int J Obes (Lond) 2006;30:350-358.
20.
Brixval CS, Andersen LB, Heitmann BL: Fat intake and weight development from 9 to 16 years of age: the European youth heart study - a longitudinal study. Obes Facts 2009;2:166-170.
21.
Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM: Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999;69:632-646.
22.
Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO: The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 2000;24:1545-1552.
23.
Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO: The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr 2000;83(suppl 1):S25-S32.
24.
Hooper L, Abdelhamid A, Moore HJ, Douthwaite W, Skeaff CM, Summerbell CD: Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ 2012;345:e7666.
25.
Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore HJ, Davey Smith G: Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2012;5:CD002137.
26.
Lee-Han H, Cousins M, Beaton M, McGuire V, Kriukov V, Chipman M, Boyd N: Compliance in a randomized clinical trial of dietary fat reduction in patients with breast dysplasia. Am J Clin Nutr 1988;48:575-586.
27.
Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, Chatfield MD, Bluck LJ, Williams CM, Sanders TA: Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 2010;92:748-758.
28.
Rissanen AM, Heliövaara M, Knekt P, Reunanen A, Aromaa A: Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr 1991;45:419-430.
29.
Sherwood NE, Jeffery RW, French SA, Hannan PJ, Murray DM: Predictors of weight gain in the pound of prevention study. Int J Obes Relat Metab Disord 2000;24:395-403.
30.
Drapeau V, Després JP, Bouchard C, Allard L, Fournier G, Leblanc C, Tremblay A: Modifications in food-group consumption are related to long-term body-weight changes. Am J Clin Nutr 2004;80:29-37.
31.
Butte NF, Cai G, Cole SA, Wilson TA, Fisher JO, Zakeri IF, Ellis KJ, Comuzzie AG: Metabolic and behavioral predictors of weight gain in Hispanic children: the Viva la Familia Study. Am J Clin Nutr 2007;85:1478-1485.
32.
Nimptsch K, Berg-Beckhoff G, Linseisen J: Effect of dietary fatty acid intake on prospective weight change in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Public Health Nutr 2010;13:1636-1646.
33.
Bo S, Ciccone G, Guidi S, Gambino R, Durazzo M, Gentile L, Cassader M, Cavallo-Perin P, Pagano G: Diet or exercise: what is more effective in preventing or reducing metabolic alterations? Eur J Endocrinol 2008;159:685-691.
34.
Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nälsén C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 2001;44:312-319.
35.
Bes-Rastrollo M, Sánchez-Villegas A, de la Fuente C, de Irala J, Martinez JA, Martínez-González MA: Olive oil consumption and weight change: the SUN prospective cohort study. Lipids 2006;41:249-256.
36.
Soriguer F, Almaraz MC, Ruiz-de-Adana MS, Esteva I, Linares F, García-Almeida JM, Morcillo S, García-Escobar E, Olveira-Fuster G, Rojo-Martínez G: Incidence of obesity is lower in persons who consume olive oil. Eur J Clin Nutr 2009;63:1371-1374.
37.
Schwingshackl L, Strasser B, Hoffmann G: Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. Ann Nutr Metab 2011;59:176-186.
38.
Gerhard GT, Ahmann A, Meeuws K, McMurry MP, Duell PB, Connor WE: Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes. Am J Clin Nutr 2004;80:668-673.
39.
Dahm CC, Gorst-Rasmussen A, Jakobsen MU, Schmidt EB, Tjønneland A, Sørensen TI, Overvad K: Adipose tissue fatty acid patterns and changes in anthropometry: a cohort study. PLoS One 2011;6:e22587.
40.
Jakobsen MU, Dethlefsen C, Due KM, Slimani N, Chajès V, May AM, Sørensen TI, Halkjær J, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Fagherazzi G, Teucher B, Kaaks R, Boeing H, Schütze M, Trichopoulou A, Zylis D, Makrygiannis G, Palli D, Mattiello A, Tagliabue G, van der A DL, Bueno-de-Mesquita HB, Rodríguez L, Travier N, Molina-Montes E, Huerta JM, Barricarte A, Amiano P, Manjer J, Wirfält E, Johansson I, Hallmans G, Khaw KT, Wareham NJ, Crowe F, Romieu I, Riboli E, Peeters PH, Overvad K: Plasma phospholipid long-chain n-3 polyunsaturated fatty acids and body weight change. Obes Facts 2011;4:312-318.
41.
Whigham LD, Watras AC, Schoeller DA: Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 2007;85:1203-1211.
42.
St-Onge MP, Ross R, Parsons WD, Jones PJ: Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 2003;11:395-402.
43.
Papamandjaris AA, White MD, Jones PJ: Components of total energy expenditure in healthy young women are not affected after 14 days of feeding with medium-versus long-chain triglycerides. Obes Res 1999;7:273-280.
44.
Krotkiewski M: Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord 2001;25:1393-1400.
45.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
46.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
47.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-297.
48.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544.
49.
Eriksson KF, Lindgärde F: Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 1991;34:891-898.
50.
Swinburn BA, Metcalf PA, Ley SJ: Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 2001;24:619-624.
51.
Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, Perri MG, Beresford SA, Robinson JG, Rodríguez B, Safford MM, Wenger NK, Stevens VJ, Parker LM; Women's Health Initiative: Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med 2008;168:1500-1511.
52.
Marshall JA, Hoag S, Shetterly S, Hamman RF: Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley diabetes study. Diabetes Care 1994;17:50-56.
53.
Feskens EJ, Virtanen SM, Räsänen L, Tuomilehto J, Stengård J, Pekkanen J, Nissinen A, Kromhout D: Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the seven countries study. Diabetes Care 1995;18:1104-1112.
54.
Salmerón J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC: Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-1026.
55.
Halton TL, Liu S, Manson JE, Hu FB: Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr 2008;87:339-346.
56.
Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR: Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001;24:1528-1535.
57.
van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB: Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002;25:417-424.
58.
Laaksonen DE, Lakka TA, Lakka HM, Nyyssönen K, Rissanen T, Niskanen LK, Salonen JT: Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 2002;19:456-464.
59.
Harding AH, Day NE, Khaw KT, Bingham S, Luben R, Welsh A, Wareham NJ: Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of Cancer-Norfolk study. Am J Epidemiol 2004;159:73-82.
60.
Simmons RK, Harding AH, Jakes RW, Welch A, Wareham NJ, Griffin SJ: How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level? Diabetologia 2006;49:905-911.
61.
Lindström J, Peltonen M, Eriksson JG, Louheranta A, Fogelholm M, Uusitupa M, Tuomilehto J: High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 2006;49:912-920.
62.
Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, Giles GG: Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007;86:189-197.
63.
Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H: Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr 2008;99:1107-1116.
64.
Micha R, Mozaffarian D: Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010;45:893-905.
65.
Song Y, Manson JE, Buring JE, Liu S: A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. Diabetes Care 2004;27:2108-2115.
66.
Kröger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Döring F, Joost HG, Boeing H, Schulze MB: Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011;93:127-142.
67.
Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH; ARIC Study Investigators: Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003;78:91-98.
68.
Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B: Fatty acid profile of the erythrocyte membrane preceding development of type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:503-510.
69.
Brostow DP, Odegaard AO, Koh WP, Duval S, Gross MD, Yuan JM, Pereira MA: Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 2011;94:520-526.
70.
Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, Djousse L, Hu FB, Mozaffarian D: Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr 2012;107(suppl 2):S214-S227.
71.
Xun P, He K: Fish consumption and incidence of diabetes: meta-analysis of data from 438,000 individuals in 12 independent prospective cohorts with an average 11-year follow-up. Diabetes Care 2012;35:930-938.
72.
Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A: Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care 2012;35:918-929.
73.
Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS: Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 2010;153:790-799.
74.
Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kröger J, Schulze MB, Crowe FL, Huerta JM, Guevara M, Beulens JW, van Woudenbergh GJ, Wang L, Summerhill K, Griffin JL, Feskens EJ, Amiano P, Boeing H, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Gonzalez C, Jakobsen MU, Kaaks R, Key TJ, Khaw KT, Kühn T, Mattiello A, Nilsson PM, Overvad K, Pala V, Palli D, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van der A DL, van der Schouw YT, Langenberg C, Riboli E, Wareham NJ: Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2014;2:810-818.
75.
Aune D, Norat T, Romundstad P, Vatten LJ: Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 2013;98:1066-1083.
76.
Nicklas TA, Dwyer J, Feldman HA, Luepker RV, Kelder SH, Nader PR: Serum cholesterol levels in children are associated with dietary fat and fatty acid intake. J Am Diet Assoc 2002;102:511-517.
77.
Lefevre M, Champagne CM, Tulley RT, Rood JC, Most MM: Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr 2005;82:957-963; quiz 1145-1146.
78.
Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, Pearson T, Roheim P, Ramakrishnan R, Reed R, Stewart K, Stewart P, Phillips K, Anderson N: Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 1998;18:441-449.
79.
Mensink RP, Katan MB: Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992;12:911-919.
80.
Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146-1155.
81.
Bonanome A, Grundy SM: Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med 1988;318:1244-1248.
82.
Effect of dietary stearic acid on plasma cholesterol level. N Engl J Med 1988;319:1089-1091.
83.
Howell WH, McNamara DJ, Tosca MA, Smith BT, Gaines JA: Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 1997;65:1747-1764.
84.
Sarkkinen ES, Uusitupa MI, Pietinen P, Aro A, Ahola I, Penttilä I, Kervinen K, Kesäniemi YA: Long-term effects of three fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 1994;105:9-23.
85.
Due A, Larsen TM, Mu H, Hermansen K, Stender S, Astrup A: Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr 2008;88:1232-1241.
86.
Niinikoski H, Lagström H, Jokinen E, Siltala M, Rönnemaa T, Viikari J, Raitakari OT, Jula A, Marniemi J, Näntö-Salonen K, Simell O: Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins: the STRIP study. Circulation 2007;116:1032-1040.
87.
Niinikoski H, Pahkala K, Ala-Korpela M, Viikari J, Rönnemaa T, Lagström H, Jokinen E, Jula A, Savolainen MJ, Simell O, Raitakari OT: Effect of repeated dietary counseling on serum lipoproteins from infancy to adulthood. Pediatrics 2012;129:e704-e713.
88.
Müller H, Lindman AS, Brantsaeter AL, Pedersen JI: The serum LDL/HDL cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in the diet of women. J Nutr 2003;133:78-83.
89.
Bos MB, de Vries JH, Feskens EJ, van Dijk SJ, Hoelen DW, Siebelink E, Heijligenberg R, de Groot LC: Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity. Nutr Metab Cardiovasc Dis 2010;20:591-598.
90.
Allman-Farinelli MA, Gomes K, Favaloro EJ, Petocz P: A diet rich in high-oleic-acid sunflower oil favorably alters low-density lipoprotein cholesterol, triglycerides, and factor VII coagulant activity. J Am Diet Assoc 2005;105:1071-1079.
91.
Gardner CD, Kraemer HC: Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995;15:1917-1927.
92.
Wien MA, Sabaté JM, Iklé DN, Cole SE, Kandeel FR: Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord 2003;27:1365-1372.
93.
Novotny JA, Gebauer SK, Baer DJ: Discrepancy between the Atwater factor predicted and empirically measured energy values of almonds in human diets. Am J Clin Nutr 2012;96:296-301.
94.
Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Stampfer MJ: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229-241.
95.
Thijssen MA, Mensink RP: Small differences in the effects of stearic acid, oleic acid, and linoleic acid on the serum lipoprotein profile of humans. Am J Clin Nutr 2005;82:510-516.
96.
Mensink RP, Katan MB: Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet 1987;1:122-125.
97.
Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U: Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 2009;139:861-868.
98.
Karvonen HM, Tapola NS, Uusitupa MI, Sarkkinen ES: The effect of vegetable oil-based cheese on serum total and lipoprotein lipids. Eur J Clin Nutr 2002;56:1094-1101.
99.
Sanders TA, Roshanai F: The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci (Lond) 1983;64:91-99.
100.
Pang D, lman-Farinelli MA, Wong T, Barnes R, Kingham KM: Replacement of linoleic acid with alpha-linolenic acid does not alter blood lipids in normolipidaemic men. Br J Nutr 1998;80:163-167.
101.
Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM: Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 2003;77:783-795.
102.
Singer P, Berger I, Wirth M, Gödicke W, Jaeger W, Voigt S: Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects. Prostaglandins Leukot Med 1986;24:173-193.
103.
Bemelmans WJ, Broer J, Feskens EJ, Smit AJ, Muskiet FA, Lefrandt JD, Bom VJ, May JF, Meyboom-de Jong B: Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-Linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr 2002;75:221-227.
104.
Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Goldin BR, Rasmussen H, McNamara JR, Ordovas JM: Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am J Clin Nutr 1996;63:234-241.
105.
Watanabe N, Watanabe Y, Kumagai M, Fujimoto K: Administration of dietary fish oil capsules in healthy middle-aged Japanese men with a high level of fish consumption. Int J Food Sci Nutr 2009;60(suppl 5):136-142.
106.
García-Alonso FJ, Jorge-Vidal V, Ros G, Periago MJ: Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women. Eur J Nutr 2012;51:415-424.
107.
Cazzola R, Russo-Volpe S, Miles EA, Rees D, Banerjee T, Roynette CE, Wells SJ, Goua M, Wahle KW, Calder PC, Cestaro B: Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. Atherosclerosis 2007;193:159-167.
108.
Damsgaard CT, Frøkiaer H, Andersen AD, Lauritzen L: Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 2008;138:1061-1066.
109.
Fontani G, Corradeschi F, Felici A, Alfatti F, Bugarini R, Fiaschi AI, Cerretani D, Montorfano G, Rizzo AM, Berra B: Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with omega-3 polyunsaturated fatty acids. Eur J Clin Invest 2005;35:499-507.
110.
Kaul N, Kreml R, Austria JA, Richard MN, Edel AL, Dibrov E, Hirono S, Zettler ME, Pierce GN: A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr 2008;27:51-58.
111.
Bernstein AM, Ding EL, Willett WC, Rimm EB: A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J Nutr 2012;142:99-104.
112.
Milte CM, Coates AM, Buckley JD, Hill AM, Howe PR: Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 2008;99:1083-1088.
113.
Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, Armah CK, Kimber AC, Grew JP, Farrell L, Stannard J, Napper FL, Sala-Vila A, West AL, Mathers JC, Packard C, Williams CM, Calder PC, Minihane AM: Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008;88:618-629.
114.
Zock PL, Katan MB: Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992;33:399-410.
115.
Mozaffarian D, Clarke R: Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009;63(suppl 2):S22-S33.
116.
Wanders AJ, Brouwer IA, Siebelink E, Katan MB: Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects. PLoS One 2010;5:e9000.
117.
Sundram K, Karupaiah T, Hayes KC: Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr Metab (Lond) 2007;4:3.
118.
Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM: Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 2006;83:237-243.
119.
Motard-Bélanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B: Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008;87:593-599.
120.
Chardigny JM, Destaillats F, Malpuech-Brugère C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, Chaumont P, Combe N, Cristiani I, Joffre F, German JB, Dionisi F, Boirie Y, Sébédio JL: Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 2008;87:558-566.
121.
Sluijs I, Plantinga Y, de Roos B, Mennen LI, Bots ML: Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 2010;91:175-183.
122.
Lambert EV, Goedecke JH, Bluett K, Heggie K, Claassen A, Rae DE, West S, Dugas J, Dugas L, Meltzeri S, Charlton K, Mohede I: Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Br J Nutr 2007;97:1001-1011.
123.
Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B: Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. J Clin Invest 1981;67:493-502.
124.
Katan MB, Beynen AC: Hyper-response to dietary cholesterol in man. Lancet 1983;1:1213.
125.
Beynen AC, Katan MB, van Zutphen BFM: Individuelle Unterschiede der Serumcholesterinreaktion auf Änderungen der Ernährungsform. Ernährungs Umschau 1985;32:356-360.
126.
Wolff E, Vergnes ME, Portugal H, Defoort C, Amiot-Carlin MJ, Lairon D, Nicolay A: Cholesterol-absorber status modifies the LDL cholesterol-lowering effect of a Mediterranean-type diet in adults with moderate cardiovascular risk factors. J Nutr 2011;141:1791-1798.
127.
Clarke R, Frost C, Collins R, Appleby P, Peto R: Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997;314:112-117.
128.
Weggemans RM, Zock PL, Katan MB: Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr 2001;73:885-891.
129.
Hopkins PN: Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. Am J Clin Nutr 1992;55:1060-1070.
130.
Fielding CJ, Havel RJ, Todd KM, Yeo KE, Schloetter MC, Weinberg V, Frost PH: Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men. J Clin Invest 1995;95:611-618.
131.
Greene CM, Zern TL, Wood RJ, Shrestha S, Aggarwal D, Sharman MJ, Volek JS, Fernandez ML: Maintenance of the LDL cholesterol: HDL cholesterol ratio in an elderly population given a dietary cholesterol challenge. J Nutr 2005;135:2793-2798.
132.
Greene CM, Waters D, Clark RM, Contois JH, Fernandez ML: Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr Metab (Lond) 2006;3:6.
133.
Hjerpsted J, Leedo E, Tholstrup T: Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr 2011;94:1479-1484.
134.
Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U: Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012;95:1003-1012.
135.
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-316.
136.
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308.
137.
Mora S, Rifai N, Buring JE, Ridker PM: Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008;118:993-1001.
138.
Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG: Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013;61:427-436.
139.
Varbo A, Benn M, Nordestgaard BG: Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther 2014;141:358-367.
140.
Howard BV, van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM: Low-fat dietary pattern and risk of cardiovascular disease: the women's health initiative randomized controlled dietary modification trial. JAMA 2006;295:655-666.
141.
Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, Bucher HC: Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:285-293.
142.
Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy WS, Kelly TN, He J, Bazzano LA: Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2012;176(suppl 7):S44-S54.
143.
Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA: Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859-873.
144.
Brussaard JH, van Raaij JM, Stasse-Wolthuis M, Katan MB, Hautvast JG: Blood pressure and diet in normotensive volunteers: absence of an effect of dietary fiber, protein, or fat. Am J Clin Nutr 1981;34:2023-2029.
145.
Margetts BM, Beilin LJ, Armstrong BK, Rouse IL, Vandongen R, Croft KD, McMurchie EJ: Blood pressure and dietary polyunsaturated and saturated fats: a controlled trial. Clin Sci (Lond) 1985;69:165-175.
146.
Sacks FM, Stampfer MJ, Munoz A, McManus K, Canessa M, Kass EH: Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr 1987;6:179-185.
147.
Mensink RP, Stolwijk AM, Katan MB: Effect of a monounsaturated diet vs. a polyunsaturated fatty acid-enriched diet on blood pressure in normotensive women and men. Eur J Clin Invest 1990;20:463-469.
148.
Zock PL, Blijlevens RA, de Vries JH, Katan MB: Effects of stearic acid and trans fatty acids versus linoleic acid on blood pressure in normotensive women and men. Eur J Clin Nutr 1993;47:437-444.
149.
Aro A, Pietinen P, Valsta LM, Salminen I, Turpeinen AM, Virtanen M, Dougherty RM, Iacono JM: Lack of effect on blood pressure by low fat diets with different fatty acid compositions. J Hum Hypertens 1998;12:383-389.
150.
Stamler J, Liu K, Ruth KJ, Pryer J, Greenland P: Eight-year blood pressure change in middle-aged men: relationship to multiple nutrients. Hypertension 2002;39:1000-1006.
151.
Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ: A prospective study of nutritional factors and hypertension among US men. Circulation 1992;86:1475-1484.
152.
Wang L, Manson JE, Forman JP, Gaziano JM, Buring JE, Sesso HD: Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension 2010;56:598-604.
153.
Shah M, Adams-Huet B, Garg A: Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials. Am J Clin Nutr 2007;85:1251-1256.
154.
Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist GM, Jandacek RJ, D'Alessio DA: One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. Diabetes Care 2009;32:215-220.
155.
Jenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, Connelly PW, Leiter LA, Josse RG, Lamarche B: Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ 2010;182:1961-1967.
156.
Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, Rivellese AA, Tapsell L, Hermansen K: Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr 2006;83:221-226.
157.
Wendland E, Farmer A, Glasziou P, Neil A: Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 2006;92:166-169.
158.
Paschos GK, Magkos F, Panagiotakos DB, Votteas V, Zampelas A: Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 2007;61:1201-1206.
159.
Appel LJ, Miller ER, Seidler AJ, Whelton PK: Does supplementation of diet with ‘fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-1438.
160.
Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-533.
161.
Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ: Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-1499.
162.
Campbell F, Dickinson HO, Critchley JA, Ford GA, Bradburn M: A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur J Prev Cardiol 2013;20:107-120.
163.
Miller PE, van Elswyk M, Alexander DD: Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014;27:885-896.
164.
Xun P, Hou N, Daviglus M, Liu K, Morris JS, Shikany JM, Sidney S, Jacobs DR, He K: Fish oil, selenium and mercury in relation to incidence of hypertension: a 20-year follow-up study. J Intern Med 2011;270:175-186.
165.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497.
166.
Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
167.
Dorgan JF, Liu L, Barton BA, Deshmukh S, Snetselaar LG, van Horn L, Stevens VJ, Robson AM, Lasser NL, Himes JH, Shepherd JA, Pourfarzib R, Pettee Gabriel K, Kriska A, Kwiterovich PO Jr: Adolescent diet and metabolic syndrome in young women: results of the Dietary Intervention Study in Children (DISC) follow-up study. J Clin Endocrinol Metab 2011;96:E1999-E2008.
168.
Ilanne-Parikka P, Eriksson JG, Lindström J, Peltonen M, Aunola S, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, Valle TT, Lahtela J, Uusitupa M, Tuomilehto J: Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 2008;31:805-807.
169.
Bo S, Ciccone G, Baldi C, Benini L, Dusio F, Forastiere G, Lucia C, Nuti C, Durazzo M, Cassader M, Gentile L, Pagano G: Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med 2007;22:1695-1703.
170.
Johnson JL, Slentz CA, Houmard JA, Samsa GP, Duscha BD, Aiken LB, McCartney JS, Tanner CJ, Kraus WE: Exercise training amount and intensity effects on metabolic syndrome (from studies of a targeted risk reduction intervention through defined exercise). Am J Cardiol 2007;100:1759-1766.
171.
Camhi SM, Stefanick ML, Katzmarzyk PT, Young DR: Metabolic syndrome and changes in body fat from a low-fat diet and/or exercise randomized controlled trial. Obesity 2010;18:548-554.
172.
Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K: Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004;27:2707-2715.
173.
Millen BE, Pencina MJ, Kimokoti RW, Zhu L, Meigs JB, Ordovas JM, D'Agostino RB: Nutritional risk and the metabolic syndrome in women: opportunities for preventive intervention from the Framingham Nutrition Study. Am J Clin Nutr 2006;84:434-441.
174.
Mirmiran P, Noori N, Azizi F: A prospective study of determinants of the metabolic syndrome in adults. Nutr Metab Cardiovasc Dis 2008;18:567-573.
175.
Ventura AK, Loken E, Birch LL: Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls. Pediatrics 2006;118:2434-2442.
176.
Salas-Salvadó J, Fernandez-Ballart J, Ros E, Martinez-Gonzalez MA, Fito M, Estruch R, Corella D, Fiol M, Gomez-Gracia E, Aros F, Flores G, Lapetra J, Lamuela-Raventos R, Ruiz-Gutierrez V, Bulló M, Basora J, Covas MI: Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008;168:2449-2458.
177.
Vanhala M, Saltevo J, Soininen P, Kautiainen H, Kangas AJ, Ala-Korpela M, Mäntyselkä P: Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol 2012;176:253-260.
178.
Baik I, Abbott RD, Curb JD, Shin C: Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010;110:1018-1026.
179.
Warensjö E, Sundström J, Lind L, Vessby B: Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 2006;84:442-448.
180.
Kiess W, Hauner H, Wabitsch M, Reinehr T (eds): Das Metabolische Syndrom im Kindes- und Jugendalter: Diagnose - Therapie - Prävention. München, Elsevier, Urban & Fischer, 2009.
181.
Mente A, de Koning L, Shannon HS, Anand SS: A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009;169:659-669.
182.
Skeaff CM, Miller J: Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009;55:173-201.
183.
Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010;7:e1000252.
184.
Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010;91:535-546.
185.
Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A: Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009;89:1425-1432.
186.
Jakobsen MU, Dethlefsen C, Joensen AM, Stegger J, Tjønneland A, Schmidt EB, Overvad K: Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010;91:1764-1768.
187.
Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E: Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014;160:398-406.
188.
Dawczynski C, Kleber ME, März W, Jahreis G, Lorkowski S: Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann Intern Med 2014;161:453-454.
189.
Willett WC, Stampfer MJ, Sacks FM: Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann Intern Med 2014;161:458.
190.
Schwingshackl L, Hoffmann G: Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis 2014;13:154.
191.
Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM: n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010;104:1586-1600.
192.
de Goede J, Verschuren WM, Boer JM, Verberne LD, Kromhout D, Geleijnse JM: N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a dutch adult population: a nested case-control study and meta-analysis. PLoS One 2013;8:e59408.
193.
Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, Willett WC, Hu FB: Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 2014;130:1568-1578.
194.
de Lorgeril M, Salen P: Dietary prevention of coronary heart disease: focus on omega-6/omega-3 essential fatty acid balance; in Simopoulos AP, Cleland LG (eds): Omega-6, Omega-3 Essential Fatty Acid Ratio: The Scientific Evidence. World Review of Nutrition and Dietetics. Basel, Karger, 2003, pp 57-73.
195.
Wolfram G: Was sind und wie wirken ω-3-Fettsäuren? Struktur, Stoffwechsel und Wirkungsmechanismen von ω-3-Fettsäuren in der Prävention kardiovaskulärer Krankheiten. Ernährungs Umschau 1997;44:S36-S41.
196.
Natvig H, Borchgrevink CF, Dedichen J, Owren PA, Schiotz EH, Westlund K: A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66. Scand J Clin Lab Invest Suppl 1968;105:1-20.
197.
Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006;296:1885-1899.
198.
Turpeinen O: Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Circulation 1979;59:1-7.
199.
Miettinen M, Turpeinen O, Karvonen MJ, Pekkarinen M, Paavilainen E, Elosuo R: Dietary prevention of coronary heart disease in women: the Finnish mental hospital study. Int J Epidemiol 1983;12:17-25.
200.
Brouwer IA, Katan MB, Zock PL: Dietary α-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004;134:919-922.
201.
Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, Mozaffarian D: α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2012;96:1262-1273.
202.
Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC: Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005;165:725-730.
203.
Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G: Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006;332:752-760.
204.
Brox J, Olaussen K, Osterud B, Elvevoll EO, Bjørnstad E, Brattebøg G, Iversen H: A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects. Lipids 2001;36:7-13.
205.
Malaguarnera M, Restuccia N, Fazio ID, Panebianco MP, Gulizia G, Giugno I: Fish oil treatment of interferon-alpha-induced dyslipidaemia: study in patients with chronic hepatitis C. BioDrugs 1999;11:285-291.
206.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-1098.
207.
Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F: Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 2012;107(suppl 2):S201-S213.
208.
Einvik G, Klemsdal TO, Sandvik L, Hjerkinn EM: A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2010;17:588-592.
209.
Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B: Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2012;5:808-818.
210.
ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S: n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-318.
211.
Musa-Veloso K, Binns MA, Kocenas A, Chung C, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S: Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease. Br J Nutr 2011;106:1129-1141.
212.
Trikalinos TA, Lee J, Moorthy D, Yu WW, Lau J, Lichtenstein AH, Chung M: Effects of Eicosapentanoic Acid and Docosahexanoic Acid on Mortality Across Diverse Settings: Systematic Review and Meta-Analysis of Randomized Trials and Prospective Cohorts. Nutritional Research Series, vol. 4. AHRQ Technical Reviews. Rockville, Agency for Healthcare Research and Quality, 2012.
213.
Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000;102:2677-2679.
214.
Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-1118.
215.
Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS: n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the cardiovascular health study. Am J Clin Nutr 2003;77:319-325.
216.
Woodward M, Tunstall-Pedoe H, Batty GD, Tavendale R, Hu FB, Czernichow S: The prognostic value of adipose tissue fatty acids for incident cardiovascular disease: results from 3,944 subjects in the Scottish Heart Health Extended Cohort Study. Eur Heart J 2011;32:1416-1423.
217.
Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS: Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 2013;158:515-525.
218.
Mozaffarian D, Aro A, Willett WC: Health effects of trans fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009;63(suppl 2):S5-S21.
219.
Bendsen NT, Christensen R, Bartels EM, Astrup A: Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr 2011;65:773-783.
220.
Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, Raynor WJ Jr: Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med 1981;304:65-70.
221.
Shekelle RB, Stamler J: Dietary cholesterol and ischaemic heart disease. Lancet 1989;1:1177-1179.
222.
McGee DL, Reed DM, Yano K, Kagan A, Tillotson J: Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to nutrient intake. Am J Epidemiol 1984;119:667-676.
223.
Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Giampaoli S, Jansen A: Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995;24:308-315.
224.
Stamler J, Shekelle R: Dietary cholesterol and human coronary heart disease. The epidemiologic evidence. Arch Pathol Lab Med 1988;112:1032-1040.
225.
Kushi LH, Lew RA, Stare FJ, Ellison CR, el Lozy M, Bourke G, Daly L, Graham I, Hickey N, Mulcahy R, et al: Diet and 20-year mortality from coronary heart disease. The Ireland-Boston diet-heart study. N Engl J Med 1985;312:811-818.
226.
Morris JN, Marr JW, Clayton DG: Diet and heart: a postscript. Br Med J 1977;2:1307-1314.
227.
Kromhout D, de Lezenne Coulander C: Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. The Zutphen study. Am J Epidemiol 1984;119:733-741.
228.
Posner BM, Cobb JL, Belanger AJ, Cupples LA, D'Agostino RB, Stokes J: Dietary lipid predictors of coronary heart disease in men. The Framingham Study. Arch Intern Med 1991;151:1181-1187.
229.
Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC: Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996;313:84-90.
230.
Esrey KL, Joseph L, Grover SA: Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. J Clin Epidemiol 1996;49:211-216.
231.
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-1499.
232.
Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997;145:876-887.
233.
de Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR Jr, Nettleton JA: Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2012;96:397-404.
234.
Harris WS: The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep 2010;12:503-508.
235.
McGee D, Reed D, Stemmerman G, Rhoads G, Yano K, Feinleib M: The relationship of dietary fat and cholesterol to mortality in 10 years: the Honolulu Heart Program. Int J Epidemiol 1985;14:97-105.
236.
Gillman MW, Cupples LA, Millen BE, Ellison RC, Wolf PA: Inverse association of dietary fat with development of ischemic stroke in men. JAMA 1997;278:2145-2150.
237.
Kagan A, Popper JS, Rhoads GG, Yano K: Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985;16:390-396.
238.
Reed DM: The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990;131:579-588.
239.
Seino F, Date C, Nakayama T, Yoshiike N, Yokoyama T, Yamaguchi M, Tanaka H: Dietary lipids and incidence of cerebral infarction in a Japanese rural community. J Nutr Sci Vitaminol 1997;43:83-99.
240.
Sauvaget C, Nagano J, Hayashi M, Yamada M: Animal protein, animal fat, and cholesterol intakes and risk of cerebral infarction mortality in the adult health study. Stroke 2004;35:1531-1537.
241.
Iso H, Stampfer MJ, Manson JE, Rexrode K, Hu F, Hennekens CH, Colditz GA, Speizer FE, Willett WC: Prospective study of fat and protein intake and risk of intraparenchymal hemorrhage in women. Circulation 2001;103:856-863.
242.
He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A: Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003;327:777-782.
243.
Boden-Albala B, Elkind MS, White H, Szumski A, Paik MC, Sacco RL: Dietary total fat intake and ischemic stroke risk: the Northern Manhattan Study. Neuroepidemiology 2009;32:296-301.
244.
Lapidus L, Andersson H, Bengtsson C, Bosaeus I: Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Clin Nutr 1986;44:444-448.
245.
Leosdottir M, Nilsson PM, Nilsson JA, Berglund G: Cardiovascular event risk in relation to dietary fat intake in middle-aged individuals: data from The Malmö Diet and Cancer Study. Eur J Cardiovasc Prev Rehabil 2007;14:701-706.
246.
Larsson SC, Virtamo J, Wolk A: Dietary fats and dietary cholesterol and risk of stroke in women. Atherosclerosis 2012;221:282-286.
247.
Atkinson C, Whitley E, Ness A, Baker I: Associations between types of dietary fat and fish intake and risk of stroke in the Caerphilly Prospective Study (CaPS). Public Health 2011;125:345-348.
248.
Iso H, Sato S, Kitamura A, Naito Y, Shimamoto T, Komachi Y: Fat and protein intakes and risk of intraparenchymal hemorrhage among middle-aged Japanese. Am J Epidemiol 2003;157:32-39.
249.
Takeya Y, Popper JS, Shimizu Y, Kato H, Rhoads GG, Kagan A: Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke 1984;15:15-23.
250.
Yamagishi K, Iso H, Yatsuya H, Tanabe N, Date C, Kikuchi S, Yamamoto A, Inaba Y, Tamakoshi A: Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study. Am J Clin Nutr 2010;92:759-765.
251.
Misirli G, Benetou V, Lagiou P, Bamia C, Trichopoulos D, Trichopoulou A: Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population. Am J Epidemiol 2012;176:1185-1192.
252.
Yaemsiri S, Sen S, Tinker L, Rosamond W, Wassertheil-Smoller S, He K: Trans fat, aspirin, and ischemic stroke in postmenopausal women. Ann Neurol 2012;72:704-715.
253.
Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, Ward H, Johnson L, Crowe F, Hu FB, Franco OH: Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ 2012;345:e6698.
254.
Larsson SC, Orsini N, Wolk A: Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur J Epidemiol 2012;27:895-901.
255.
He K: Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease - eat fish or take fish oil supplement? Prog Cardiovasc Dis 2009;52:95-114.
256.
US Department of Agriculture: Composition of foods raw, processed, prepared. USDA nutritional nutrient database for standard reference. Release 24, 2011. www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/SR24/sr24_doc.pdf (accessed June 12, 2013).
257.
World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, 2007.
258.
World Cancer Research Fund, American Institute for Cancer Research: WCRF/AICR systematic literature review continuous update report. The associations between food, nutrition and physical activity and the risk of breast cancer. 2008. http://www.dietandcancerreport.org/cancer_resource_center/downloads/cu/Breast-Cancer-SLR-2008.pdf (accessed March 5, 2014).
259.
World Cancer Research Fund, American Institute for Cancer Research: WCRF/AICR systematic literature review continuous update project report. The associations between food, nutrition and physical activity and the risk of colorectal cancer. 2010. http://www.dietandcancerreport.org/cancer_resource_center/downloads/cu/Colorectal-Cancer-SLR-2010.pdf (accessed March 5, 2014).
260.
World Cancer Research Fund, American Institute for Cancer Research: WCRF/AICR systematic literature review continuous update project report. The associations between food, nutrition and physical activity and the risk of pancreatic cancer. 2011. http://www.dietandcancerreport.org/cancer_resource_center/downloads/cu/Pancreatic-Cancer-SLR-2011.pdf (accessed March 5, 2014).
261.
World Cancer Research Fund, American Institute for Cancer Research: WCRF/AICR systematic literature review continuous update project. The associations between food, nutrition and physical activity and the risk of endometrial cancer. 2012. http://www.dietandcancerreport.org/cancer_resource_center/downloads/cu/Endometrial-Cancer-SLR-2012.pdf (accessed March 5, 2014).
262.
Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, Pettinger M, Lane DS, Lessin L, Yasmeen S, Singh B, Khandekar J, Shikany JM, Satterfield S, Chlebowski RT: Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst 2007;99:1534-1543.
263.
Liu L, Zhuang W, Wang RQ, Mukherjee R, Xiao SM, Chen Z, Wu XT, Zhou Y, Zhang HY: Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies. Eur J Nutr 2011;50:173-184.
264.
Dahm CC, Keogh RH, Lentjes MA, Spencer EA, Key TJ, Greenwood DC, Cade JE, Burley VJ, Shipley MJ, Brunner EJ, Stephen AM, Mishra G, Kuh D, Fentiman IS, White IR, Luben R, Khaw KT, Rodwell Bingham SA: Intake of dietary fats and colorectal cancer risk: prospective findings from the UK dietary cohort consortium. cancer epidemiol 2010;34:562-567.
265.
World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, 1997.
266.
Smith-Warner SA, Ritz J, Hunter DJ, Albanes D, Beeson WL, van den Brandt PA, Colditz G, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Kushi LH, Miller AB, Rohan TE, Speizer FE, Virtamo J, Willett WC: Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 2002;11:987-992.
267.
Allen NE, Appleby PN, Key TJ, Bueno-de-Mesquita HB, Ros MM, Kiemeney LA, Tjønneland A, Roswall N, Overvad K, Weikert S, Boeing H, Chang-Claude J, Teucher B, Panico S, Sacerdote C, Tumino R, Palli D, Sieri S, Peeters P, Quirós JR, Jakszyn P, Molina-Montes E, Chirlaque MD, Ardanaz E, Dorronsoro M, Khaw KT, Wareham N, Ljungberg B, Hallmans G, Ehrnström R, Ericson U, Gram IT, Parr CL, Trichopoulou A, Karapetyan T, Dilis V, Clavel-Chapelon F, Boutron-Ruault MC, Fagherrazzi G, Romieu I, Gunter MJ, Riboli E: Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer 2013;132:635-644.
268.
Arem H, Mayne ST, Sampson J, Risch H, Stolzenberg-Solomon RZ: Dietary fat intake and risk of pancreatic cancer in the prostate, lung, colorectal and ovarian cancer screening trial. Ann Epidemiol 2013;23:571-575.
269.
Turner LB: A meta-analysis of fat intake, reproduction, and breast cancer risk: an evolutionary perspective. Am J Hum Biol 2011;23:601-608.
270.
Park SY, Kolonel LN, Henderson BE, Wilkens LR: Dietary fat and breast cancer in postmenopausal women according to ethnicity and hormone receptor status: the Multiethnic Cohort Study. Cancer Prev Res (Phila) 2012;5:216-228.
271.
Sczaniecka AK, Brasky TM, Lampe JW, Patterson RE, White E: Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. Nutr Cancer 2012;64:1131-1142.
272.
Key TJ, Appleby PN, Cairns BJ, Luben R, Dahm CC, Akbaraly T, Brunner EJ, Burley V, Cade JE, Greenwood DC, Stephen AM, Mishra G, Kuh D, Keogh RH, White IR, Bhaniani A, Borgulya G, Mulligan AA, Khaw KT: Dietary fat and breast cancer: comparison of results from food diaries and food-frequency questionnaires in the UK dietary cohort consortium. Am J Clin Nutr 2011;94:1043-1052.
273.
Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA: Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomarkers Prev 2014;23:255-273.
274.
Blank MM, Wentzensen N, Murphy MA, Hollenbeck A, Park Y: Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study. Br J Cancer 2012;106:596-602.
275.
Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL: Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 2007;165:802-813.
276.
Crowe FL, Key TJ, Appleby PN, Travis RC, Overvad K, Jakobsen MU, Johnsen NF, Tjønneland A, Linseisen J, Rohrmann S, Boeing H, Pischon T, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Krogh V, Bueno-de-Mesquita HB, Kiemeney LA, Chirlaque MD, Ardanaz E, Sánchez MJ, Larrañaga N, González CA, Quirós JR, Manjer J, Wirfält E, Stattin P, Hallmans G, Khaw KT, Bingham S, Ferrari P, Slimani N, Jenab M, Riboli E: Dietary fat intake and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Am J Clin Nutr 2008;87:1405-1413.
277.
Pelser C, Mondul AM, Hollenbeck AR, Park Y: Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev 2013;22:697-707.
278.
Bassett JK, Severi G, Hodge AM, Macinnis RJ, Gibson RA, Hopper JL, English DR, Giles GG: Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 2013;133:1882-1891.
279.
Bandera EV, Kushi LH, Moore DF, Gifkins DM, McCullough ML: Dietary lipids and endometrial cancer: the current epidemiologic evidence. Cancer Causes Control 2007;18:687-703.
280.
Cui X, Rosner B, Willett WC, Hankinson SE: Dietary fat, fiber, and carbohydrate intake in relation to risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2011;20:978-989.
281.
Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjønneland A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Zavitsanou A, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Agnoli C, Kiemeney LA, Bueno-de-Mesquita HB, Chirlaque MD, Ardanaz E, Larrañaga N, Quirós JR, Sánchez MJ, González CA, Stattin P, Hallmans G, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ: Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European prospective investigation into cancer and nutrition. Am J Clin Nutr 2008;88:1353-1363.
282.
Dahm CC, Gorst-Rasmussen A, Crowe FL, Roswall N, Tjønneland A, Drogan D, Boeing H, Teucher B, Kaaks R, Adarakis G, Zylis D, Trichopoulou A, Fedirko V, Chajes V, Jenab M, Palli D, Pala V, Tumino R, Ricceri F, van Kranen H, Bueno-de-Mesquita HB, Quirós JR, Sánchez MJ, Luján-Barroso L, Larrañaga N, Chirlaque MD, Ardanaz E, Johansson M, Stattin P, Khaw KT, Wareham N, Wark PA, Norat T, Riboli E, Key TJ, Overvad K: Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2012;96:1354-1361.
283.
Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, Goodman MT, Murphy SP, Henderson BE, Kolonel LN: Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 2009;20:211-223.
284.
Daniel CR, McCullough ML, Patel RC, Jacobs EJ, Flanders WD, Thun MJ, Calle EE: Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol Biomarkers Prev 2009;18:516-525.
285.
Butler LM, Wang R, Koh WP, Stern MC, Yuan JM, Yu MC: Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer 2009;124:678-686.
286.
Sasazuki S, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Takachi R, Tsugane S: Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan Public Health Center-based prospective study. Int J Cancer 2011;129:1718-1729.
287.
Chua ME, de Sio MC, Sorongon MC, Dy JS: Relationship of dietary intake of omega-3 and omega-6 fatty acids with risk of prostate cancer development: a meta-analysis of prospective studies and review of literature. Prostate Cancer 2012;2012:826254.
288.
Sakai M, Kakutani S, Horikawa C, Tokuda H, Kawashima H, Shibata H, Okubo H, Sasaki S: Arachidonic acid and cancer risk: a systematic review of observational studies. BMC Cancer 2012;12:606.
289.
Gerber M: Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 2012;107(suppl 2):S228-S239.
290.
Shen XJ, Zhou JD, Dong JY, Ding WQ, Wu JC: Dietary intake of n-3 fatty acids and colorectal cancer risk: a meta-analysis of data from 489 000 individuals. Br J Nutr 2012;108:1550-1556.
291.
Zheng JS, Hu XJ, Zhao YM, Yang J, Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 2013;346:f3706.
292.
Hall MN, Chavarro JE, Lee IM, Willett WC, Ma J: A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2008;17:1136-1143.
293.
Qin B, Xun P, He K: Fish or long-chain (n-3) PUFA intake is not associated with pancreatic cancer risk in a meta-analysis and systematic review. J Nutr 2012;142:1067-1073.
294.
Yang B, Ren XL, Fu YQ, Gao JL, Li D: Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies. BMC Cancer 2014;14:105.
295.
Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC, Giovannucci EL: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 2004;80:204-216.
296.
Koralek DO, Peters U, Andriole G, Reding D, Kirsh V, Subar A, Schatzkin A, Hayes R, Leitzmann MF: A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States). Cancer Causes Control 2006;17:783-791.
297.
Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 2013;105:1132-1141.
298.
Brasky TM, Till C, White E, Neuhouser ML, Song X, Goodman P, Thompson IM, King IB, Albanes D, Kristal AR: Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol 2011;173:1429-1439.
299.
Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährung: Referenzwerte für die Nährstoffzufuhr, ed 2. Bonn, 2015.
300.
Deutsche Gesellschaft für Ernährung e.V.: Vollwertig essen und trinken nach den 10 Regeln der DGE, ed 25. Bonn, 2013.
301.
Stehle P, Oberritter H, Büning-Fesel M, Heseker H: Grafische Umsetzung von Ernährungsrichtlinien - traditionelle und neue Ansätze. Ernährungs Umschau 2005;52:128-135.
302.
Jungvogel A, Wendt I, Schäbethal K, Leschik-Bonnet E, Oberritter H: Überarbeitet: Die 10 Regeln der DGE. Ernährungs Umschau 2013;59:M644-M645.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
